Vivian S. Lee, M.D., Ph.D., M.B.A. joined Verily in May 2018. She also serves as a Senior Fellow at the Institute for Healthcare Improvement. Dr. Lee is the former Dean, SVP and CEO University of Utah Health. As a leading healthcare executive, she is contributing to the advancement of value-driven transformation in health care (NYT Corner Office, STAT). As CEO, Lee led University of Utah Health to recognition for its health care delivery system innovations (Algorithmsforinnovation.org) that enable higher quality at lower costs (JAMA & editorial, NYT) and with higher patient satisfaction (NYT, HBR, NEJM), as well as successful strategies of faculty development and mentorship. In 2016, University of Utah was ranked first among university hospitals in quality and safety (Vizient). The University’s health plan grew five-fold and was successful in the individual exchange. As Dean, she led the significant expansion of the School of Medicine class size with increased state funding, and helped raise large philanthropic gifts.
Elected to the National Academy of Medicine, Lee is an MR radiologist who developed novel methods for measuring kidney function and vascular disease with MRI. Funded by the NIH for 20 years, Dr. Lee was elected to National Academy of Medicine (formerly, the Institute of Medicine) in 2015. She serves on the NIH Council of Councils advisory to the NIH Director and has authored over 175 peer-reviewed research publications (link).
Dr. Lee is a magna cum laude graduate of Harvard-Radcliffe Colleges, received a doctorate in medical engineering from Oxford University as a Rhodes Scholar, earned her M.D. with honors from Harvard Medical School, and was valedictorian of her EMBA program at Stern School of Business, at NYU. She is also a director on the boards of two publicly traded companies, Merrimack Pharmaceuticals and Zions Bancorporation.